The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
Open accessAbstract
The Wnt signaling pathways are a group of signal transduction pathways that play an important role in cell fate specification, cell proliferation and cell migration. Aberrant signaling in these pathways has been implicated in the development and progression of multiple cancers by allowing increased proliferation, angiogenesis, survival and metastasis. Activation of the Wnt pathway also contributes to the tumorigenicity of cancer stem cells (CSCs). Therefore, inhibiting this pathway has been a recent focus for cancer research with multiple targetable candidates in development. OMP-54F28 is a fusion protein that combines the cysteine-rich domain of frizzled family receptor 8 (Fzd8) with the immunoglobulin Fc domain that competes with the native Fzd8 receptor for its ligands and antagonizes Wnt signaling. Preclinical models with OMP-54F28 have shown reduced tumor growth and decreased CSC frequency as a single agent and in combination with other chemotherapeutic agents. Due to these findings, a phase 1a study is nearing completion with OMP-54F28 in advanced solid tumors and 3 phase 1b studies have been opened with OMP-54F28 in combination with standard of care chemotherapy backbones in ovarian, pancreatic and hepatocellular cancers. This article will review the Wnt signaling pathway, preclinical data on OMP-54F28 and other Wnt pathway inhibitors and ongoing clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations affecting segment number and polarity in Drosophila
Nüsslein-Volhard, C., & Wieschaus, E. (1980) · Nature · doi:10.1038/287795a0 · Cited by 4,370
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
Functional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
β-catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,529
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Wnt proteins are lipid-modified and can act as stem cell growth factors
Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., Yates, J. R., & Nusse, R. (2003) · Nature · doi:10.1038/nature01611 · Cited by 2,257
A role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159
Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism
Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G.-H., Tan, Y., Zhang, Z., Lin, X., & He, X. (2002) · Cell · doi:10.1016/s0092-8674(02)00685-2 · Cited by 2,069
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
Nusse, R., & Varmus, H. E. (1982) · Cell · doi:10.1016/0092-8674(82)90409-3 · Cited by 1,863
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2048 · Cited by 1,804
Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous Polyposis
Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., & Offerhaus, G. J. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305063281805 · Cited by 1,717
Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction
Glinka, A., Wu, W., Delius, H., Monaghan, A. P., Blumenstock, C., & Niehrs, C. (1998) · Nature · doi:10.1038/34848 · Cited by 1,608
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4
Korinek, V., Barker, N., Moerer, P., van Donselaar, E., Huls, G., Peters, P. J., & Clevers, H. (1998) · Nature Genetics · doi:10.1038/1270 · Cited by 1,581
A new member of the frizzled family from Drosophila functions as a Wingless receptor
Bhanot, P., Brink, M., Samos, C. H., Hsieh, J.-C., Wang, Y., Macke, J. P., Andrew, D., Nathans, J., & Nusse, R. (1996) · Nature · doi:10.1038/382225a0 · Cited by 1,502
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485 · cited 1×
“High levels of Wnt expression was also observed in granulocyte-macrophage progenitors isolated from chronic myeloid leukemia (CML) patients and correlated with increased self-renewal (Jamieson et al., 2004).”
BackgroundOzawa, M., Baribault, H., & Kemler, R. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03563.x · Cited by 1,396
Localization of the gene for familial adenomatous polyposis on chromosome 5
Bodmer, W. F., Bailey, C. J., Bodmer, J., Bussey, H. J. R., Ellis, A., Gorman, P., Lucibello, F. C., Murday, V. A., Rider, S. H., Scambler, P., et al. (1987) · Nature · doi:10.1038/328614a0 · Cited by 1,390
Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer
Chen, B., Dodge, M. E., Tang, W., Lu, J., Ma, Z., Fan, C.-W., Wei, S., Hao, W., Kilgore, J., Williams, N. S., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.137 · Cited by 1,383
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
Piccirillo, S. G. M., Reynolds, B. A., Zanetti, N., Lamorte, G., Binda, E., Broggi, G., Brem, H., Olivi, A., Dimeco, F., & Vescovi, A. L. (2006) · Nature · doi:10.1038/nature05349 · Cited by 1,176
Yost, C., Torres, M., Miller, J. R., Huang, E., Kimelman, D., & Moon, R. T. (1996) · Genes & Development · doi:10.1101/gad.10.12.1443 · Cited by 1,165
LDL-receptor-related proteins in Wnt signal transduction
Tamai, K., Semenov, M., Kato, Y., Spokony, R., Liu, C., Katsuyama, Y., Hess, F., Saint-Jeannet, J.-P., & He, X. (2000) · Nature · doi:10.1038/35035117 · Cited by 1,128
Batlle, E., Henderson, J. T., Beghtel, H., van den Born, M. M. W., Sancho, E., Huls, G., Meeldijk, J., Robertson, J., van de Wetering, M., Pawson, T., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01015-2 · Cited by 1,120
De Novo Hair Follicle Morphogenesis and Hair Tumors in Mice Expressing a Truncated β-Catenin in Skin
Gat, U., DasGupta, R., Degenstein, L., & Fuchs, E. (1998) · Cell · doi:10.1016/s0092-8674(00)81631-1 · Cited by 1,089
WNT Signals Are Required for the Initiation of Hair Follicle Development
Andl, T., Reddy, S. T., Gaddapara, T., & Millar, S. E. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00167-3 · Cited by 1,088
An LDL-receptor-related protein mediates Wnt signalling in mice
Pinson, K. I., Brennan, J., Monkley, S., Avery, B. J., & Skarnes, W. C. (2000) · Nature · doi:10.1038/35035124 · Cited by 1,086
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer
Suzuki, H., Watkins, D. N., Jair, K.-W., Schuebel, K. E., Markowitz, S. D., Dong Chen, W., Pretlow, T. P., Yang, B., Akiyama, Y., van Engeland, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1330 · Cited by 1,069
Rijsewijk, F., Schuermann, M., Wagenaar, E., Parren, P., Weigel, D., & Nusse, R. (1987) · Cell · doi:10.1016/0092-8674(87)90038-9 · Cited by 931
A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription
Emami, K. H., Nguyen, C., Ma, H., Kim, D. H., Jeong, K. W., Eguchi, M., Moon, R. T., Teo, J.-L., Oh, S. W., Kim, H. Y., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404875101 · Cited by 874
arrow encodes an LDL-receptor-related protein essential for Wingless signalling
Wehrli, M., Dougan, S. T., Caldwell, K., O'Keefe, L., Schwartz, S., Vaizel-Ohayon, D., Schejter, E., Tomlinson, A., & DiNardo, S. (2000) · Nature · doi:10.1038/35035110 · Cited by 871
Nuclear localization of β-catenin by interaction with transcription factor LEF-1
Huber, O., Korn, R., McLaughlin, J., Ohsugi, M., Herrmann, B. G., & Kemler, R. (1996) · Mechanisms of Development · doi:10.1016/0925-4773(96)00597-7 · Cited by 856
A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation
Zeng, X., Tamai, K., Doble, B., Li, S., Huang, H., Habas, R., Okamura, H., Woodgett, J., & He, X. (2005) · Nature · doi:10.1038/nature04185 · Cited by 849
Mao, J., Wang, J., Liu, B., Pan, W., Farr, G. H., Flynn, C., Yuan, H., Takada, S., Kimelman, D., Li, L., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00224-6 · Cited by 839 · cited 9×
“AXIN also interacts with the plasma membrane, possibly by binding the cytoplasmic tail of LRP5/6 (Mao et al., 2001).”
BackgroundInfluentialTargeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Liu, J., Pan, S., Hsieh, M. H., Ng, N., Sun, F., Wang, T., Kasibhatla, S., Schuller, A. G., Li, A. G., Cheng, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314239110 · Cited by 831
Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration
Sansom, O. J., Reed, K. R., Hayes, A. J., Ireland, H., Brinkmann, H., Newton, I. P., Batlle, E., Simon-Assmann, P., Clevers, H., Nathke, I. S., et al. (2004) · Genes & Development · doi:10.1101/gad.287404 · Cited by 799
Sun, Y., Campisi, J., Higano, C., Beer, T. M., Porter, P., Coleman, I., True, L., & Nelson, P. S. (2012) · Nature Medicine · doi:10.1038/nm.2890 · Cited by 793 · cited 1×
“Wnt expression has been correlated with therapy resistance in prostate cancer, where Wnt16B increased following therapy and lessened DNA damage following treatment with a topoisomerase inhibitor (Sun et al., 2012).”
BackgroundA new secreted protein that binds to Wnt proteins and inhibits their activites
Hsieh, J.-C., Kodjabachian, L., Rebbert, M. L., Rattner, A., Smallwood, P. M., Samos, C. H., Nusse, R., Dawid, I. B., & Nathans, J. (1999) · Nature · doi:10.1038/18899 · Cited by 750
Tsukamoto, A. S., Grosschedl, R., Guzman, R. C., Parslow, T., & Varmus, H. E. (1988) · Cell · doi:10.1016/0092-8674(88)90220-6 · Cited by 747
Mining the Wnt pathway for cancer therapeutics
Barker, N., & Clevers, H. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2154 · Cited by 743
Wnt Signaling and an APC-Related Gene Specify Endoderm in Early C. elegans Embryos
Rocheleau, C. E., Downs, W. D., Lin, R., Wittmann, C., Bei, Y., Cha, Y.-H., Ali, M., Priess, J. R., & Mello, C. C. (1997) · Cell · doi:10.1016/s0092-8674(00)80531-0 · Cited by 660
Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex
Lepourcelet, M., Chen, Y.-N. P., France, D. S., Wang, H., Crews, P., Petersen, F., Bruseo, C., Wood, A. W., & Shivdasani, R. A. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00334-9 · Cited by 653
E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton.
Hülsken, J., Birchmeier, W., & Behrens, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.6.2061 · Cited by 647
Gurney, A., Axelrod, F., Bond, C. J., Cain, J., Chartier, C., Donigan, L., Fischer, M., Chaudhari, A., Ji, M., Kapoun, A. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120068109 · Cited by 614 · cited 2×
“…In vitro cell proliferation HNSCC Rhee et al. 2002 OMP-18R5 Fzd1,2,5,7, and 8 In vivo tumor growth CRC, breast, pancreatic, NSCLC, teratocarcinoma Gurney et al. 2012 WIF1-Fc and sFRP-Fc Wnt ligands In vitro cell proliferation, in vitro cell death, in vivo tumor growth Hepatocellular Hu et al.…”
BackgroundWNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis
Nguyen, D. X., Chiang, A. C., Zhang, X. H.-F., Kim, J. Y., Kris, M. G., Ladanyi, M., Gerald, W. L., & Massagué, J. (2009) · Cell · doi:10.1016/j.cell.2009.04.030 · Cited by 613
WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells
Woodward, W. A., Chen, M. S., Behbod, F., Alfaro, M. P., Buchholz, T. A., & Rosen, J. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606599104 · Cited by 603
Casein kinase 1 γ couples Wnt receptor activation to cytoplasmic signal transduction
Davidson, G., Wu, W., Shen, J., Bilic, J., Fenger, U., Stannek, P., Glinka, A., & Niehrs, C. (2005) · Nature · doi:10.1038/nature04170 · Cited by 581
McMahon, A. P., & Moon, R. T. (1989) · Cell · doi:10.1016/0092-8674(89)90506-0 · Cited by 529
Wnt Signaling Polarizes an Early C. elegans Blastomere to Distinguish Endoderm from Mesoderm
Thorpe, C. J., Schlesinger, A., Carter, J. C., & Bowerman, B. (1997) · Cell · doi:10.1016/s0092-8674(00)80530-9 · Cited by 514
Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?
Takahashi-Yanaga, F., & Kahn, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2943 · Cited by 499
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
Thorne, C. A., Hanson, A. J., Schneider, J., Tahinci, E., Orton, D., Cselenyi, C. S., Jernigan, K. K., Meyers, K. C., Hang, B. I., Waterson, A. G., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.453 · Cited by 485
Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains
Dann, C. E., Hsieh, J.-C., Rattner, A., Sharma, D., Nathans, J., & Leahy, D. J. (2001) · Nature · doi:10.1038/35083601 · Cited by 473
Inhibition of Wnt/β-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis
Henderson, W. R., Chi, E. Y., Ye, X., Nguyen, C., Tien, Y.-T., Zhou, B., Borok, Z., Knight, D. A., & Kahn, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001520107 · Cited by 462
Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia.
Zhang, X., Gaspard, J. P., & Chung, D. C. (2001) · PubMed · Cited by 427
Lu, D., Choi, M. Y., Yu, J., Castro, J. E., Kipps, T. J., & Carson, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110431108 · Cited by 395
Defining the impact of β-catenin/Tcf transactivation on epithelial stem cells
Lowry, W. E., Blanpain, C., Nowak, J. A., Guasch, G., Lewis, L., & Fuchs, E. (2005) · Genes & Development · doi:10.1101/gad.1324905 · Cited by 392
A new nomenclature for int-1 and related genes: The Wnt gene family
Nusse, R., Brown, A., Papkoff, J., Scambler, P., Shackleford, G., McMahon, A., Moon, R., & Varmus, H. (1991) · Cell · doi:10.1016/0092-8674(91)90633-a · Cited by 368
Vinson, C. R., Conover, S., & Adler, P. N. (1989) · Nature · doi:10.1038/338263a0 · Cited by 367
A Role for the Wnt Gene Family in Hematopoiesis: Expansion of Multilineage Progenitor Cells
Austin, T. W., Solar, G. P., Ziegler, F. C., Liem, L., & Matthews, W. (1997) · Blood · doi:10.1182/blood.v89.10.3624 · Cited by 360
Hsieh, J.-C., Rattner, A., Smallwood, P. M., & Nathans, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3546 · Cited by 349
The Frizzled family: receptors for multiple signal transduction pathways.
Huang, H., & Klein, P. S. (2004) · Genome biology · doi:10.1186/gb-2004-5-7-234 · Cited by 349
Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer
Aguilera, O., Fraga, M. F., Ballestar, E., Paz, M. F., Herranz, M., Espada, J., García, J. M., Muñoz, A., Esteller, M., & González-Sancho, J. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209439 · Cited by 338
Quercetin, a potent inhibitor against β-catenin/Tcf signaling in SW480 colon cancer cells
Park, C. H., Chang, J. Y., Hahm, E. R., Park, S., Kim, H.-K., & Yang, C. H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.151 · Cited by 337
beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran, V., Lee, S. H., Inge, L. J., Guo, L., Goldbeck, C., Garrett, E. N., Wiesmann, M., García, P. D., Fuller, J. H., Chan, V. W.-F., et al. (2003) · PubMed · Cited by 334
Wissmann, C., Wild, P. J., Kaiser, S., Roepcke, S., Stoehr, R., Woenckhaus, M., Kristiansen, G., Hsieh, J., Hofstaedter, F., Hartmann, A., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1449 · Cited by 333
Choi, Y. S., Zhang, Y., Xu, M., Yang, Y., Ito, M., Peng, T., Cui, Z., Nagy, A., Hadjantonakis, A.-K., Lang, R. A., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.10.003 · Cited by 330
Moon, R. T., Campbell, R. M., Christian, J. L., McGrew, L. L., Shih, J., & Fraser, S. (1993) · Development · doi:10.1242/dev.119.1.97 · Cited by 329
Waaler, J., Machon, O., Tumova, L., Dinh, H., Korinek, V., Wilson, S. R., Paulsen, J. E., Pedersen, N. M., Eide, T. J., Machonova, O., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3336 · Cited by 328
An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells
Bafico, A., Liu, G., Goldin, L., Harris, V., & Aaronson, S. A. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.032 · Cited by 324
Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression
Uematsu, K., He, B., You, L., Xu, Z., McCormick, F., & Jablons, D. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206817 · Cited by 314
Fujino, H., West, K. A., & Regan, J. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109440200 · Cited by 310
Rothbächer, U., Laurent, M. N., Deardorff, M. A., Klein, P. S., Cho, K. W. Y., & Fraser, S. E. (2000) · The EMBO Journal · doi:10.1093/emboj/19.5.1010 · Cited by 299
FZD7 has a critical role in cell proliferation in triple negative breast cancer
Yang, L., Wu, X., Wang, Y., Zhang, K., Wu, J., Yuan, Y.-C., Deng, X., Chen, L., Kim, C. C. H., Lau, S., et al. (2011) · Oncogene · doi:10.1038/onc.2011.145 · Cited by 297
Fu, Y., Chang, H., Peng, X., Bai, Q., Yi, L., Zhou, Y., Zhu, J., & Mi, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102535 · Cited by 295
Wnt Inhibitory Factor-1 Is Silenced by Promoter Hypermethylation in Human Lung Cancer
Mazieres, J., He, B., You, L., Xu, Z., Lee, A. Y., Mikami, I., Reguart, N., Rosell, R., McCormick, F., & Jablons, D. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1389 · Cited by 271
A Monoclonal Antibody against Wnt-1 Induces Apoptosis in Human Cancer Cells
He, B., You, L., Uematsu, K., Xu, Z., Lee, A. Y., Matsangou, M., McCormick, F., & Jablons, D. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80048-4 · Cited by 269
Phenocopies induced with antisense RNA identify the wingless gene
Cabrera, C. V., Alonso, M. C., Johnston, P., Phillips, R. G., & Lawrence, P. A. (1987) · Cell · doi:10.1016/0092-8674(87)90039-0 · Cited by 260
You, L., He, B., Xu, Z., Uematsu, K., Mazieres, J., Mikami, I., Reguart, N., Moody, T. W., Kitajewski, J., McCormick, F., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207844 · Cited by 258
Wnt/β-Catenin Signaling Induces Proliferation, Survival and Interleukin-8 in Human Endothelial Cells
Masckauchán, T. N. H., Shawber, C. J., Funahashi, Y., Li, C.-M., & Kitajewski, J. (2005) · Angiogenesis · doi:10.1007/s10456-005-5612-9 · Cited by 249
Peifer, M., Pai, L.-M., & Casey, M. (1994) · Developmental Biology · doi:10.1006/dbio.1994.1336 · Cited by 248
Hoang, B., Moos, M., Vukicevic, S., & Luyten, F. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26131 · Cited by 248
Holcombe, R. F., Nguyen, A., Martinez, Stamos, M. J., Moyer, M. P., Planutis, K., Hope, & Holcombe, R. F. (2009) · Cancer Management and Research · doi:10.2147/cmar.s4544 · Cited by 248
Zhai, L., Chaturvedi, D., & Cumberledge, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403407200 · Cited by 247
Wnt signalling in lung development and diseases
Pongracz, J. E., & Stockley, R. A. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-15 · Cited by 242
Mao, J., Fan, S., Ma, W., Fan, P., Wang, B., Zhang, J., Wang, H., Tang, B., Zhang, Q., Yu, X., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2013.515 · Cited by 241
Shan, B.-E., Wang, M.-X., & Li, R.-Q. (2009) · Cancer Investigation · doi:10.1080/07357900802337191 · Cited by 240
Targeted Inhibition of β-Catenin/CBP Signaling Ameliorates Renal Interstitial Fibrosis
Hao, S., He, W., Li, Y., Ding, H., Hou, Y., Nie, J., Hou, F. F., Kahn, M., & Liu, Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010101079 · Cited by 238
Fujii, N., You, L., Xu, Z., Uematsu, K., Shan, J., He, B., Mikami, I., Edmondson, L. R., Neale, G., Zheng, J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2726 · Cited by 232
Lu, W., Lin, C., Roberts, M. J., Waud, W. R., Piazza, G. A., & Li, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029290 · Cited by 230 · cited 3×
“In this study, Dvl2 was unperturbed, and decreased cell proliferation and apoptosis induction was observed in prostate and breast cancer cells (Lu et al., 2011b).”
BackgroundMasckauchán, T. N. H., Agalliu, D., Vorontchikhina, M., Ahn, A., Parmalee, N. L., Li, C.-M., Khoo, A., Tycko, B., Brown, A. M. C., & Kitajewski, J. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-04-0320 · Cited by 223
In vivo transcriptional governance of hair follicle stem cells by canonical Wnt regulators
Lien, W.-H., Polak, L., Lin, M., Lay, K., Zheng, D., & Fuchs, E. (2014) · Nature Cell Biology · doi:10.1038/ncb2903 · Cited by 217
Nguyen, A. V., Martinez, M. E., Stamos, M. J., Moyer, M. P., Planutis, K., Hope, C., & Holcombe, R. F. (2009) · PubMed Central · Cited by 216
Casein kinase Iɛ in the Wnt pathway: Regulation of β-catenin function
Sakanaka, C., Leong, P., Xu, L., Harrison, S. D., & Williams, L. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12548 · Cited by 213
The Anti-Helminthic Niclosamide Inhibits Wnt/Frizzled1 Signaling
Chen, M., Wang, J., Lu, J., Bond, M. C., Ren, X.-R., Lyerly, H. K., Barak, L. S., & Chen, W. (2009) · Biochemistry · doi:10.1021/bi9009677 · Cited by 213
Identification of a Specific Inhibitor of the Dishevelled PDZ Domain
Shan, J., Shi, D.-L., Wang, J., & Zheng, J. (2005) · Biochemistry · doi:10.1021/bi0512602 · Cited by 213
He, B., Reguart, N., You, L., Mazieres, J., Xu, Z., Lee, A. Y., Mikami, I., McCormick, F., & Jablons, D. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208511 · Cited by 212
Discovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of Dishevelled
Grandy, D., Shan, J., Zhang, X., Rao, S., Akunuru, S., Li, H., Zhang, Y., Alpatov, I., Zhang, X. A., Lang, R. A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.009647 · Cited by 201
You, L., He, B., Xu, Z., Uematsu, K., Mazieres, J., Fujii, N., Mikami, I., Reguart, N., McIntosh, J. K., Kashani-Sabet, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1227 · Cited by 194
Urakami, S., Shiina, H., Enokida, H., Kawakami, T., Tokizane, T., Ogishima, T., Tanaka, Y., Li, L.-C., Ribeiro-Filho, L. A., Terashima, M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1344 · Cited by 189
Trosset, J., Dalvit, C., Knapp, S., Fasolini, M., Veronesi, M., Mantegani, S., Gianellini, L. M., Catana, C., Sundström, M., Stouten, P. F. W., et al. (2006) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20955 · Cited by 181
Rhee, C.-S., Sen, M., Lu, D., Wu, C., Leoni, L., Rubin, J., Corr, M., & Carson, D. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205920 · Cited by 179
Fukui, T., Kondo, M., Ito, G., Maeda, O., Sato, N., Yoshioka, H., Yokoi, K., Ueda, Y., Shimokata, K., & Sekido, Y. (2005) · Oncogene · doi:10.1038/sj.onc.1208777 · Cited by 172
Chen, M. S., Woodward, W. A., Behbod, F., Peddibhotla, S., Alfaro, M. P., Buchholz, T. A., & Rosen, J. M. (2007) · Journal of Cell Science · doi:10.1242/jcs.03348 · Cited by 170
Anticancer Effects of Niclosamide in Human Glioblastoma
Wieland, A., Trageser, D., Gogolok, S., Reinartz, R., Höfer, H., Keller, M., Leinhaas, A., Schelle, R., Normann, S., Klaas, L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2895 · Cited by 168
Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer
Arend, R. C., Londoño-Joshi, A. I., Samant, R. S., Li, Y., Conner, M., Hidalgo, B., Alvarez, R. D., Landen, C. N., Straughn, J. M., & Buchsbaum, D. J. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.04.005 · Cited by 161 · cited 2×
“Niclosamide has also been used to target basal-like breast, liver, brain and ovarian cancer (Arend et al., 2014; Londono-Joshi et al., 2014; Tomizawa et al., 2013; Wieland et al., 2013; Yo et al., 2012).”
BackgroundInhibition of Tankyrases Induces Axin Stabilization and Blocks Wnt Signalling in Breast Cancer Cells
Bao, R., Christova, T., Song, S., Angers, S., Yan, X., & Attisano, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048670 · Cited by 161
Salinomycin inhibits osteosarcoma by targeting its tumor stem cells
Tang, Q.-L., Zhao, Z.-Q., Li, J.-C., Liang, Y., Yin, J.-Q., Zou, C.-Y., Xie, X.-B., Zeng, Y.-X., Shen, J.-N., Kang, T., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.07.016 · Cited by 159
The Wnt/β-Catenin Signaling Pathway as a Target in Drug Discovery
Takahashi‐Yanaga, F., & Sasaguri, T. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.cr0070024 · Cited by 158
Jin, X., Jeon, H.-Y., Joo, K. M., Kim, J.-K., Jin, J., Kim, S.-H., Kang, B. G., Beck, S. J., Lee, S. J., Kim, J. K., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1495 · Cited by 156
Wnt5a cloning, expression, and up-regulation in human primary breast cancers.
LeJeune, S., Huguet, E., Hamby, A. M., Poulsom, R., & Harris, A. L. (1995) · PubMed · Cited by 152
Song, J. H., Chang, I., Chen, Z., Kang, M., & Wang, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011456 · Cited by 151
Characterization of Mouse Dishevelled (Dvl) Proteins in Wnt/Wingless Signaling Pathway
Lee, J.-S., Ishimoto, A., & Yanagawa, S.-I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21464 · Cited by 151
Eating bone or adding it: the Wnt pathway decides
Goldring, S. R., & Goldring, M. B. (2007) · Nature Medicine · doi:10.1038/nm0207-133 · Cited by 144
The Soluble Wnt Receptor Frizzled8CRD-hFc Inhibits the Growth of Teratocarcinomas In vivo
DeAlmeida, V. I., Li, M., Ernst, J. A., Koeppen, H., Polakis, P. G., & Rubinfeld, B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0266 · Cited by 139
Blockade of Wnt Signaling Inhibits Angiogenesis and Tumor Growth in Hepatocellular Carcinoma
Hu, J., Dong, A., Fernández-Ruiz, V., Shan, J., Kawa, M. P., Martínez‐Ansó, E., Prìeto, J., & Qian, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0541 · Cited by 138
Ueda, M., Gemmill, R. M., West, J. D., Winn, R., Sugita, M., Tanaka, N., Ueki, M., & Drabkin, H. A. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1863 · Cited by 132
Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells
Wang, Y.-C., Chao, T., Chang, C., Yo, Y.-T., Yu, M.-H., & Lai, H.-C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074538 · Cited by 132
Li, N., Xi, Y., Tinsley, H. N., Gurpinar, E., Gary, B. D., Zhu, B., Li, Y., Chen, X., Keeton, A. B., Abadi, A., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0048 · Cited by 132
Ye, T., Xiong, Y., Yan, Y., Xia, Y., Song, X., Liu, L., Li, D., Wang, N., Zhang, L., Zhu, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085887 · Cited by 130
Wang, F., He, L., Dai, W., Xu, Y., Wu, D., Lin, C., Wu, S.-M., Cheng, P., Zhang, Y., Shen, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050638 · Cited by 127
Tian, X., Hou, W., Fang, Y., Fan, J., Tong, H., Bai, S., Qu, C., Xu, H. J., & Li, Y. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-100 · Cited by 125
Ueno, K., Hazama, S., Mitomori, S., Nishioka, M., Suehiro, Y., Hirata, H., Oka, M., Imai, K., Dahiya, R., & Hinoda, Y. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605307 · Cited by 124
Lü, W., & Li, Y. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24850 · Cited by 123
Growth Inhibition of Ovarian Tumor–Initiating Cells by Niclosamide
Yo, Y.-T., Lin, Y.-W., Wang, Y.-C., Balch, C., Huang, R., Chan, M. W. Y., Sytwu, H., Chen, C.-K., Chang, C., Nephew, K. P., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0002 · Cited by 122
The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway
Chen, H., Hsu, L.-S., Shia, Y.-T., Lin, M., & Lin, C.-M. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.011 · Cited by 120
Frizzled homolog proteins, microRNAs and Wnt signaling in cancer
Ueno, K., Hirata, H., Hinoda, Y., & Dahiya, R. (2012) · International Journal of Cancer · doi:10.1002/ijc.27746 · Cited by 117
The CREB-Binding Protein Inhibitor ICG-001 Suppresses Pancreatic Cancer Growth
Arensman, M. D., Telesca, D., Lay, A. R., Kershaw, K. M., Wu, N., Donahue, T. R., & Dawson, D. W. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-1005 · Cited by 114
Shih, Y., Shyu, R., Hsieh, C., Lai, H., Liu, K., Chu, T., & Lin, Y. (2006) · Cancer · doi:10.1002/cncr.22023 · Cited by 113
Zhang, P., Li, H., Yang, B., Yang, F., Zhang, L., Kong, Q., Chen, X.-Y., Wu, M., & Liu, J. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.15 · Cited by 106
Rampias, T., Boutati, E., Pectasides, E., Sasaki, C., Kountourakis, P., Weinberger, P., & Psyrri, A. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0345 · Cited by 105
Wnt/β‐catenin signalling induces MLL to create epigenetic changes in salivary gland tumours
Wend, P., Fang, L., Zhu, Q., Schipper, J. H., Loddenkemper, C., Kosel, F., Brinkmann, V., Eckert, K., Hindersin, S., Holland, J. D., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.127 · Cited by 103
Inhibition of Wnt-1 Signaling Induces Apoptosis in β-Catenin-Deficient Mesothelioma Cells
You, L., He, B., Uematsu, K., Xu, Z., Mazières, J., Lee, A. Y., McCormick, F. P., & Jablons, D. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0115 · Cited by 100
Effect of Niclosamide on Basal-like Breast Cancers
Londoño-Joshi, A. I., Arend, R. C., Aristizabal, L., Lu, W., Samant, R. S., Metge, B. J., Hidalgo, B., Grizzle, W. E., Conner, M., Forero-Torres, A., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0555 · Cited by 97
Sasaki, T., Hwang, H., Nguyen, C., Kloner, R. A., & Kahn, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075010 · Cited by 91
Whitt, J. D., Nan, L., Tinsley, H. N., Chen, X., Zhang, W., Li, Y., Gary, B. D., Keeton, A. B., Xi, Y., Abadi, A., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0559 · Cited by 83
Holland, J. D., Győrffy, B., Vogel, R., Eckert, K., Valenti, G., Fang, L., Lohneis, P., Elezkurtaj, S., Ziebold, U., & Birchmeier, W. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.001 · Cited by 76
Chen, Z., Venkatesan, A. M., Dehnhardt, C. M., dos Santos, O., Santos, E. D., Ayral‐Kaloustian, S., Chen, L., Geng, Y., Arndt, K. T., Lucas, J., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.07.070 · Cited by 74
Fukukawa, C., Nagayama, S., Tsunoda, T., Toguchida, J., Nakamura, Y., & Katagiri, T. (2009) · Oncogene · doi:10.1038/onc.2008.467 · Cited by 73
Chang, H. W., Roh, J., Jeong, E., Lee, S., Kim, S., Choi, S., Park, S., & Kim, S. Y. (2007) · International Journal of Cancer · doi:10.1002/ijc.23069 · Cited by 67
Peerlinck, I., Merron, A., Baril, P., Conchon, S., Martín‐Duque, P., Hindorf, C., Burnet, J., Quintanilla, M., Hingorani, M., Iggo, R. D., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0262 · Cited by 66
Kim, H., Seo, E.-M., Sharma, A. R., Ganbold, B., Park, J., Sharma, G., Kang, Y., Song, D., Lee, S., & Nam, J. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2036 · Cited by 62
Frizzled-8 as a putative therapeutic target in human lung cancer
Wang, H.-Q., Xu, M.-L., Ma, J., Zhang, Y., & Xie, C. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.055 · Cited by 55
Synergistic Effects of Combined Wnt/KRAS Inhibition in Colorectal Cancer Cells
Mologni, L., Brussolo, S., Ceccon, M., & Gambacorti-Passerini, C. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051449 · Cited by 53
Efficacy of Wnt-1 monoclonal antibody in sarcoma cells
Mikami, I., You, L., He, B., Xu, Z., Batra, S., Lee, A. Y., Mazières, J., Reguart, N., Uematsu, K., Koizumi, K., et al. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-53 · Cited by 52
Arafat, K., Iratni, R., Takahashi, T., Parekh, K. A., Dhaheri, Y. A., Adrian, T. E., & Attoub, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066931 · Cited by 49
Lukashev, A. N., Fuerer, C., Chen, M., Searle, P. F., & Iggo, R. D. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1473 · Cited by 46
Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells.
Chen, R., & McCormick, F. (2001) · PubMed · Cited by 45
Many, A. M., & Brown, A. M. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101800 · Cited by 45
Deng, Y., Su, Q., Mo, J., Fu, X., Zhang, Y., & Lin, E. H. (2012) · Cancer Investigation · doi:10.3109/07357907.2012.754458 · Cited by 42
Fuerer, C., & Iggo, R. D. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302148 · Cited by 39
The suppression of colon cancer cell growth in nude mice by targetingβ-catenin/TCF pathway
Kwong, K. Y., Zou, Y., Day, C., & Hung, M. (2002) · Oncogene · doi:10.1038/sj.onc.1206050 · Cited by 39
The impact of pyrvinium pamoate on colon cancer cell viability
Wiegering, A., Uthe, F.-W., Hüttenrauch, M., Mühling, B., Linnebacher, M., Krummenast, F., Germer, C.-T., Thalheimer, A., & Otto, C. (2014) · International Journal of Colorectal Disease · doi:10.1007/s00384-014-1975-y · Cited by 37
Optimization of a synthetic $beta;-catenin-dependent promoter for tumor-specific cancer gene therapy
Lipinski, K. S., Djeha, H., Gawn, J. M., Cliffe, S., Maitland, N. J., Palmer, D. H., Mountain, A., Irvine, A. S., & Wrighton, C. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.03.021 · Cited by 31
Wu, D., Zhang, Y., Huang, J., Fan, Z., Shi, F., & Wang, S. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.12.032 · Cited by 29
Shen, C., Kang, Y., Zhao, M., He, Y., Cui, D., Fu, Y., Yang, L., & Gou, L. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150712928 · Cited by 26
Niclosamide suppresses hepatoma cell proliferation via the Wnt pathway
Tomizawa, M., Shinozaki, F., Motoyoshi, Y., Sugiyama, T., Yamamoto, S., Sueishi, M., & Yoshida, T. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s50065 · Cited by 26
Qiu, W., Lei, M., Li, J., Wang, N., & Lian, X. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.8383 · Cited by 22
WIF1 can effectively co-regulate pro-apoptotic activity through the combination with DKK1
Ko, Y. B., Kim, B.-R., Yoon, K., Choi, E. K., Seo, S. H., Lee, Y., Lee, M. A., Yang, J. B., Park, M. S., & Rho, S. B. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.07.026 · Cited by 18
Tumour supressor secreted frizzled related protein 1 regulates p53‐mediated apoptosis
Gauger, K. J., & Schneider, S. S. (2013) · Cell Biology International · doi:10.1002/cbin.10176 · Cited by 17
Smith, D. C., Gordon, M. S., Messersmith, W. A., Chugh, R. K., Mendelson, D. S., Dupont, J., Stagg, R., Kapoun, A. M., Xu, L., Brachmann, R. K., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.targ-13-b79 · Cited by 17
Self-citationTwo Natural ent-kauranoids as Novel Wnt Signaling Inhibitors
Zhang, J., Kong, L., Zhan, R., Ye, Z.-N., Pu, J., Sun, H., & Li, Y. (2014) · Natural Products and Bioprospecting · doi:10.1007/s13659-014-0016-4 · Cited by 11
Cited by
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Targeting the Wnt/β-catenin signaling pathway in cancer
Zhang, Y., & Wang, X. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00990-3 · Cited by 1,431
Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
Krishnamurthy, N., & Kurzrock, R. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.11.002 · Cited by 1,026
Wnt/β-catenin signaling in cancers and targeted therapies
Yu, F., Yu, C., Li, F., Zuo, Y., Wang, Y., Yao, L., Wu, C., Wang, C., & Ye, L. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00701-5 · Cited by 734
Wnt/beta-catenin pathway: modulating anticancer immune response
Pai, S. G., Carneiro, B. A., Mota, J. M., Costa, R., Leite, C. A., Barroso-Sousa, R., Kaplan, J. B., Chae, Y. K., & Giles, F. J. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0471-6 · Cited by 703
Metadata
- Authors
- Le, P. N., McDermott, J. D., & Jimeno, A.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 146
- Pages
- 1-11
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2045031715
- Cited by
- 253
- References
- 160
- FWCI
- 9.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.